These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
877 related articles for article (PubMed ID: 13130383)
1. Pharmacological studies supporting the therapeutic use of Ginkgo biloba extract for Alzheimer's disease. Ahlemeyer B; Krieglstein J Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S8-14. PubMed ID: 13130383 [TBL] [Abstract][Full Text] [Related]
2. Inhibition of serum deprivation- and staurosporine-induced neuronal apoptosis by Ginkgo biloba extract and some of its constituents. Ahlemeyer B; Möwes A; Krieglstein J Eur J Pharmacol; 1999 Feb; 367(2-3):423-30. PubMed ID: 10079019 [TBL] [Abstract][Full Text] [Related]
3. Neuroprotective effects of bilobalide, a component of Ginkgo biloba extract (EGb 761) in global brain ischemia and in excitotoxicity-induced neuronal death. Chandrasekaran K; Mehrabian Z; Spinnewyn B; Chinopoulos C; Drieu K; Fiskum G Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S89-94. PubMed ID: 13130395 [TBL] [Abstract][Full Text] [Related]
4. Bilobalide, a component of the Ginkgo biloba extract (EGb 761), protects against neuronal death in global brain ischemia and in glutamate-induced excitotoxicity. Chandrasekaran K; Mehrabian Z; Spinnewyn B; Chinopoulos C; Drieu K; Fiskum G Cell Mol Biol (Noisy-le-grand); 2002 Sep; 48(6):663-9. PubMed ID: 12396077 [TBL] [Abstract][Full Text] [Related]
5. The Ginkgo biloba extract (EGb 761) protects and rescues hippocampal cells against nitric oxide-induced toxicity: involvement of its flavonoid constituents and protein kinase C. Bastianetto S; Zheng WH; Quirion R J Neurochem; 2000 Jun; 74(6):2268-77. PubMed ID: 10820186 [TBL] [Abstract][Full Text] [Related]
6. Neuroprotective effects of bilobalide, a component of the Ginkgo biloba extract (EGb 761), in gerbil global brain ischemia. Chandrasekaran K; Mehrabian Z; Spinnewyn B; Drieu K; Fiskum G Brain Res; 2001 Dec; 922(2):282-92. PubMed ID: 11743961 [TBL] [Abstract][Full Text] [Related]
7. Structure-activity studies with Ginkgo biloba extract constituents as receptor-gated chloride channel blockers and modulators. Chatterjee SS; Kondratskaya EL; Krishtal OA Pharmacopsychiatry; 2003 Jun; 36 Suppl 1():S68-77. PubMed ID: 13130392 [TBL] [Abstract][Full Text] [Related]
8. Effects of single intraperitoneal injections of an extract of Ginkgo biloba (EGb 761) and its terpene trilactone constituents on barbital-induced narcosis in the mouse. Brochet D; Chermat R; DeFeudis FV; Drieu K Gen Pharmacol; 1999 Sep; 33(3):249-56. PubMed ID: 10480658 [TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of NV-31, a bilobalide-derived compound: evidence for an antioxidative mechanism. Ahlemeyer B; Junker V; Hühne R; Krieglstein J Brain Res; 2001 Feb; 890(2):338-42. PubMed ID: 11164801 [TBL] [Abstract][Full Text] [Related]
10. Effects of repeated treatments with an extract of Ginkgo biloba (EGb 761), bilobalide and ginkgolide B on the electrical activity of pancreatic beta cells of normal or alloxan-diabetic mice: an ex vivo study with intracellular microelectrodes. Vasseur M; Jean T; DeFeudis FV; Drieu K Gen Pharmacol; 1994 Jan; 25(1):31-46. PubMed ID: 8026711 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacokinetic properties of Bilobalide and Ginkgolides A and B in healthy subjects after intravenous and oral administration of Ginkgo biloba extract (EGb 761)]. Fourtillan JB; Brisson AM; Girault J; Ingrand I; Decourt JP; Drieu K; Jouenne P; Biber A Therapie; 1995; 50(2):137-44. PubMed ID: 7631288 [TBL] [Abstract][Full Text] [Related]
12. Distinct role of bilobalide and ginkgolide A in the modulation of rat CYP2B1 and CYP3A23 gene expression by Ginkgo biloba extract in cultured hepatocytes. Chang TK; Chen J; Teng XW Drug Metab Dispos; 2006 Feb; 34(2):234-42. PubMed ID: 16258077 [TBL] [Abstract][Full Text] [Related]
13. Complementary cardioprotective effects of flavonoid metabolites and terpenoid constituents of Ginkgo biloba extract (EGb 761) during ischemia and reperfusion. Liebgott T; Miollan M; Berchadsky Y; Drieu K; Culcasi M; Pietri S Basic Res Cardiol; 2000 Oct; 95(5):368-77. PubMed ID: 11099163 [TBL] [Abstract][Full Text] [Related]
14. Antioxidant effects of ginkgolides and bilobalide against cerebral ischemia injury by activating the Akt/Nrf2 pathway in vitro and in vivo. Liu Q; Jin Z; Xu Z; Yang H; Li L; Li G; Li F; Gu S; Zong S; Zhou J; Cao L; Wang Z; Xiao W Cell Stress Chaperones; 2019 Mar; 24(2):441-452. PubMed ID: 30815818 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of bilobalide, ginkgolide A and B after administration of three different Ginkgo biloba L. preparations in humans. Woelkart K; Feizlmayr E; Dittrich P; Beubler E; Pinl F; Suter A; Bauer R Phytother Res; 2010 Mar; 24(3):445-50. PubMed ID: 20041430 [TBL] [Abstract][Full Text] [Related]
16. [Ginkgo biloba extract (EGb 761). State of knowledge in the dawn of the year 2000]. Clostre F Ann Pharm Fr; 1999 Jul; 57 Suppl 1():1S8-88. PubMed ID: 10481350 [TBL] [Abstract][Full Text] [Related]
17. Effects of extract of Ginkgo biloba leaves and its constituents on carcinogen-metabolizing enzyme activities and glutathione levels in mouse liver. Sasaki K; Hatta S; Wada K; Ueda N; Yoshimura T; Endo T; Sakata M; Tanaka T; Haga M Life Sci; 2002 Feb; 70(14):1657-67. PubMed ID: 11991253 [TBL] [Abstract][Full Text] [Related]
18. Antioxidative activity of ginkgolides against superoxide in an aprotic environment. Scholtyssek H; Damerau W; Wessel R; Schimke I Chem Biol Interact; 1997 Oct; 106(3):183-90. PubMed ID: 9413545 [TBL] [Abstract][Full Text] [Related]